MetaCap

Regentis Biomaterials Ltd. Company Profile

NYSE: RGNTHealthcareMedical Instruments & SuppliesUSD

1.70+0.07 (+4.29%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Regentis Biomaterials at a glance

Regentis Biomaterials Ltd. (NYSE: RGNT) is a Medical Instruments & Supplies company in the Healthcare sector headquartered in Herzliya, Israel. Regentis Biomaterials is led by Dr. Ehud Geller Ph.D.. The company's shares have traded publicly since 2025.

At a market capitalization of $11.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001912966, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Regentis Biomaterials do?

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Business description based on the company's public filings.

Company information

Legal name
Regentis Biomaterials Ltd.
Ticker
NYSE: RGNT
Industry
Medical Instruments & Supplies
CEO
Dr. Ehud Geller Ph.D.
Headquarters
60, Medinat Hayehudim, Herzliya, Israel
Phone
972 9 960 1917
IPO year
2025
Market cap
$11.94M
SEC CIK
0001912966

Companies similar to Regentis Biomaterials

RGNT peer companies
CompanyPrice% ChgMarket capCompare
CUPRCuprina Holdings (Cayman) Limited Class A1.90-4.52%$13.31Mvs RGNT
LUCYInnovative Eyewear Inc.0.8967-1.68%$7.81Mvs RGNT
FEMYFemasys Inc.2.05+2.25%$17.13Mvs RGNT
BNGOBionano Genomics Inc.1.460.00%$17.19Mvs RGNT
RVPRetractable Technologies Inc.0.662-4.17%$19.82Mvs RGNT
NXGLNexGel Inc0.15-15.35%$1.46Mvs RGNT
MLSSMilestone Scientific Inc.0.36-2.70%$32.62Mvs RGNT
NEPHNephros Inc.3.29+2.81%$35.73Mvs RGNT

Related